The U.S. Attorney's Office for the Western District of New York issued a subpoena to Medtronic seeking information about the company's neurostimulation products, according to a Wall Street Journal report.
The Oct. 14 subpoena was related to the sales, marketing and reimbursement support practices of Medtronic's neurostimulation devices. Medtronic has said that it will cooperate with the investigation.
Read the Wall Street Journal report on Medtronic's subpoena.
Read other coverage on Medtronic:
- Medtronic Receives First FDA Clearance in Pediatric AIS Category for CD Horizon Spinal System
- Medtronic Receives FDA 510(k) Clearance for Spinal Cord Stimulator Trialing Cable
- Medtronic Partners With Ziehm Imaging in 3D Intraoperative Technology
The Oct. 14 subpoena was related to the sales, marketing and reimbursement support practices of Medtronic's neurostimulation devices. Medtronic has said that it will cooperate with the investigation.
Read the Wall Street Journal report on Medtronic's subpoena.
Read other coverage on Medtronic:
- Medtronic Receives First FDA Clearance in Pediatric AIS Category for CD Horizon Spinal System
- Medtronic Receives FDA 510(k) Clearance for Spinal Cord Stimulator Trialing Cable
- Medtronic Partners With Ziehm Imaging in 3D Intraoperative Technology